Larvol Delta - Brepocitinib-Demonstrates-Consistent-Clinical-Responses-Along-With-Reduced-Oral-Corticosteroid-Use-in-Dermatomyositis-Patients-With-Interstitial-Lung-Disease-Results-From-the-Phase-3-VALOR-Trial

Lisraya (brepocitinib) - Priovant Therap

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1898481&mode=presInfo

Aravind Menon, MD

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next